Genentech, Inc. NDC Codes

Overview

Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.

Drugs

Hemlibra, Xofluza, Actemra, CellCept, TNKase, Rozlytrek, Tamiflu, Lunsumio Velo, Evrysdi, Itovebi, Xolair, Columvi, Lunsumio, Phesgo, Polivy

Active ingredients

Hyaluronidase (Human recombinant), Emicizumab, Baloxavir marboxil, Tocilizumab, Mosunetuzumab, Omalizumab, Trastuzumab, Rituximab, Atezolizumab, Entrectinib, Ranibizumab, Pertuzumab

NDC labeler codes

0004, 50242

Strengths

Baloxavir marboxil 40 mg/1; Hyaluronidase (Human recombinant) 30000 U/15mL; Tocilizumab 162 mg/.9mL; Rituximab 120 mg/mL; Hyaluronidase (Human recombinant) 2000 U/mL; Trastuzumab emtansine 20 mg/mL; Rituximab 10 mg/mL; Mosunetuzumab 5 mg/.5mL; Mosunetuzumab 45 mg/mL; Baloxavir marboxil 30 mg/1; Risdiplam 5 mg/1; Inavolisib 9 mg/1; Inavolisib 3 mg/1; Ocrelizumab 920 mg/23mL; Hyaluronidase (Human recombinant) 23000 U/23mL; Atezolizumab 1875 mg/15mL; Crovalimab 340 mg/2mL; Emicizumab 12 mg/.4mL; Entrectinib 50 mg/201; Omalizumab 300 mg/2mL

Dosage forms

Injection, Solution, Capsule, Tablet, Film coated, Injection, Powder, Lyophilized, For solution, Kit, Injection, Solution, Concentrate, Injection, Concentrate, Granule, For suspension, Tablet, Coated, Powder, For suspension, Tablet, Pellet, Solution, Concentrate, Powder, For solution, Granule, For solution, Solution

Routes

Oral, Subcutaneous, Intravenous, Intravitreal, Respiratory (Inhalation)

Drug classes (FDA established)

CD20-directed Cytolytic Antibody, Endoglycosidase, HER2/neu Receptor Antagonist, Kinase Inhibitor, Polymerase Acidic Endonuclease Inhibitor, Vascular Endothelial Growth Factor Inhibitor, Interleukin-6 Receptor Antagonist, Anti-IgE, Antimetabolite Immunosuppressant, Programmed Death Receptor-1 Blocking Antibody, Neuraminidase Inhibitor, Survival of Motor Neuron 2 Splicing Modifier, Bispecific CD20-directed CD3 T Cell Engager, Pyridone, Complement C5 Inhibitor, Hedgehog Pathway Inhibitor, Recombinant Human Deoxyribonuclease 1

HCPCS / J-code

J2777 — Injection, faricimab-svoa, 0.1 mg, J2778 — Injection, ranibizumab, 0.1 mg, J9022 — Injection, atezolizumab, 10 mg, J9355 — Injection, trastuzumab, excludes biosimilar, 10 mg, J9035 — Injection, bevacizumab, 10 mg, J9312 — Injection, rituximab, 10 mg

Package NDCs

122

NDC codes

Newest listings first. Each row links to the product’s NDC page.

Genentech, Inc.: common questions

What is Genentech, Inc.'s NDC labeler code?

0004, 50242. The labeler code is the first segment of each NDC. About labeler codes.

Is there a J-code for Genentech, Inc.?

Med-Code's HCPCS directory matches J2777, J2778, J9022, J9355, J9035, J9312 to these products. NDC vs J-code.

Which NDC goes on a claim?

The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.